Sunday, February 25, 2024
Saturday, February 24, 2024
The center does not hold.
"Iran's military forces have, in an armed clash inside the Pakistani territory, killed senior Jaish al-Adl militant group commander Ismail Shahbakhsh and some of his companions," Iran's state-run media reported on Saturday.
The development has come a month after the two countries conducted airstrikes on each other's territories.
Jaish al-Adl, a Sunni extremist organization, that is designated a terrorist organization by Iran, operates predominantly in the southeastern province of Sistan-Baluchistan (colored brown left).
Centrifugal forces are acting on Iran.
Wednesday, February 21, 2024
Less for the same price
New tuna tin with less tuna. The price remains the same.
I did not realize the change and bought eight boxes.
Sunday, February 18, 2024
Decapitating the enemy
According to Gallant (Israel's Minister of Defense), “Hamas has no confidence in its commanders – this is very, very apparent. In addition, the Hamas-Gaza branch is unresponsive – there is nobody to talk to on the ground, and the external leadership [abroad] is looking for leadership [in Gaza]. This means that there is a ‘bid’ for who will manage Gaza – there is no party in control.
This is an opportunity to put some Hamas chieftain of our liking into the leadership position in Gaza and negotiate their surrender "with ourselves".
Friday, February 16, 2024
Packed Plant
Packed WWTP with automatization was my idea 30 years ago. I proposed to build a prototype to a Start-Up State facility in Southern Israel, the project was accepted but the terms were leonine, they wanted most of the shares and my part was to be about 10-15%, so I abandoned the whole project. I see now that the Chinese have produced it successfully and selling it at about 12000 dollars each (43,000 sheqel). It is dirt cheap. The factory is in Shandong and has sales of 1.5 million dollars. Admirable.
Wednesday, February 14, 2024
Is TEVA cheap?
TEVA's stock rose 3-4% today, so some people think it is interesting. We can see from the most recent balance sheet that Teva Pharmaceutical Industries had liabilities of US$11.4b falling due within a year, and liabilities of US$23.2b due beyond that. Offsetting these obligations, it had cash of US$2.25b as well as receivables valued at US$3.39b due within 12 months. So it has liabilities totaling US$28.9b more than its cash and near-term receivables, combined.
The graph shows that TEVA gradually is paying back its debt and reducing the total amount of debt. It looks encouraging. Let's sleep on it.
Subscribe to:
Posts (Atom)